Inventor · disambiguated record
Christopher Carreras
Also filed as: CARRERAS CHRISTOPHER
27 granted patents·13 pending applications·145 citations·filing 2001–2025
96Inventor score
Top patents by PatentIndex Score
40 records- 0191US8541448B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersCHARMOT DOMINIQUE·Filed 2011·Granted Sep 24, 2013·6 cites·6 claims
- 0289US9408840B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorderARDELYX INC·Filed 2015·Granted Aug 9, 2016·6 cites·6 claims
- 0389US6562795B2Motilide compoundsKOSAN BIOSCIENCES INC·Filed 2001·Granted May 13, 2003·34 cites·6 claims
- 0488US10543207B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Jan 28, 2020·3 cites·43 claims
- 0587US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 0687US8969377B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Mar 3, 2015·3 cites·7 claims
- 0786US8916569B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Dec 23, 2014·7 cites·44 claims
- 0886US8809339B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 19, 2014·8 cites·36 claims
- 0985US10272079B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 30, 2019·5 cites·15 claims
- 1085US8815910B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·38 claims
- 1185US8815908B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·32 claims
- 1284US11318129B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2020·Granted May 3, 2022·1 cites·19 claims
- 1383US10385024B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Aug 20, 2019·3 cites·36 claims
- 1483US7211568B29-Desoxoerythromycin compounds as prokinetic agentsKOSAN BIOSCIENCES INC·Filed 2004·Granted May 1, 2007·17 cites·15 claims
- 1582US2024366589A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2024·Application pending·0 cites
- 1681US12016856B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2022·Granted Jun 25, 2024·0 cites·2 claims
- 1781US9006281B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Granted Apr 14, 2015·1 cites·15 claims
- 1879US6946482B2Motilide compoundsKOSAN BIOSCIENCES INC·Filed 2003·Granted Sep 20, 2005·10 cites·14 claims
- 1979US6750205B2Motilide compoundsKOSAN BIOSCIENCES INC·Filed 2003·Granted Jun 15, 2004·11 cites·6 claims
- 2078US10940146B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 2176US6875576B2Method for evaluating therapeutic efficacyKOSAN BIOSCIENCES INC·Filed 2002·Granted Apr 5, 2005·11 cites·8 claims
- 2270US2021186953A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2020·Application pending·0 cites
- 2369US11813304B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Nov 14, 2023·0 cites·14 claims
- 2469US2024366590A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 2566US2024325487A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2023·Application pending·0 cites
- 2663US7407941B2N-desmethyl-N-substituted-11-deoxyerythromycin compoundsPFIZER·Filed 2004·Granted Aug 5, 2008·1 cites·4 claims
- 2763US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 2862US9301951B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 5, 2016·0 cites·40 claims
- 2958US9289429B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·33 claims
- 3058US9289430B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·35 claims
- 3158US9278102B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 8, 2016·0 cites·29 claims
- 3258US2025367188A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2025·Application pending·0 cites
- 3353US2016184387A1Compounds and methods for inhibiting phosphate transportCHARMOT DOMINIQUE·Filed 2014·Application pending·0 cites
- 3451US2005113319A111-Deoxy-6,9-ether erythromycin compoundsFiled 2004·Application pending·0 cites
- 3551US2015299131A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Application pending·0 cites
- 3649US2017037010A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2016·Application pending·0 cites
- 3745US7582611B2Motilide compoundsPFIZER·Filed 2006·Granted Sep 1, 2009·0 cites·16 claims
- 3843US2015336892A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2013·Application pending·0 cites
- 3943US2015148311A1Non-systemic tgr5 agonistsARDELYX INC·Filed 2014·Application pending·0 cites
- 4042US2014023611A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Carreras files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →